<qa>  What STUDY TO EVALUATE EFFICACY AND SAFETY OFA PHASE 3 STUDY TO EVALUATE EFFICACY AND SAFETY OF MASITINIB IN COMPARISON TO IMATINIB IN PATIENTS WITH GASTRO-INTESTINAL STROMAL TUMOUR IN FIRST LINE MEDICAL TREATMENT: 